Get the Stockscreener App
18.61
1.06%
-0.20
After Hours:
18.61
Tandem Diabetes Care Inc stock is traded at $18.61, with a volume of 1.03M.
It is down -1.06% in the last 24 hours and down -26.24% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$18.81
Open:
$18.25
24h Volume:
1.03M
Relative Volume:
0.54
Market Cap:
$1.27B
Revenue:
$1.01B
Net Income/Loss:
$-204.71M
P/E Ratio:
-6.0637
EPS:
-3.0691
Net Cash Flow:
$-29.67M
1W Performance:
-20.20%
1M Performance:
-26.24%
6M Performance:
+41.95%
1Y Performance:
-1.48%
1-Day Range:
$18.08
$19.09
1-Week Range:
$18.08
$22.97
52-Week Range:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
18.61 | 1.29B | 1.01B | -204.71M | -29.67M | -3.0691 |
ABT
Abbott Laboratories
|
102.87 | 177.90B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.16B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 110.49B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 92.14B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.85B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-19-26 | Upgrade | Truist | Hold → Buy |
| Mar-17-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-23-26 | Upgrade | Lake Street | Hold → Buy |
| Feb-20-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-27-26 | Resumed | TD Cowen | Buy |
| Dec-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-25 | Resumed | Stifel | Hold |
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Tandem Diabetes Care to Announce Q1 2026 Results on May 7 - National Today
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 - businesswire.com
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Diabetes Focused MiniMed Recovery Story Builds As Pipeline ImprovesMinimed Group (NASDAQ:MMED) - Benzinga
Earnings Report: Should value investors consider Tandem Diabetes Care Inc2026 Top Decliners & Fast Momentum Entry Tips - baoquankhu1.vn
Tandem Diabetes Care Stock Hits Day Low Amid Price Pressure at $20.93 - Markets Mojo
Stock List: Research Stocks from Around the World - GuruFocus
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
Board asks shareholders to approve 3.26M-share increase; TNDM files proxy (TNDM) - Stock Titan
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6%Time to Sell? - MarketBeat
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - TradingView
[SCHEDULE 13G/A] TANDEM DIABETES CARE INC Amended Passive Investment Disclosure - Stock Titan
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Mizuho maintains Tandem Diabetes Care (TNDM) neutral recommendation - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - msn.com
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch - MarketBeat
Here’s why the Brown Capital Management Small Company Fund sold Tandem Diabetes Care (TNDM) - MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now - MSN
US875372AE4 Latest News and Headlines - TradingView
US875372AE4 Bond Analysis — Key Metrics - TradingView
Tandem upgraded at Truist on pharmacy model (TNDM:NASDAQ) - Seeking Alpha
US875372AE4 Bond Price and Chart — FWB:US875372AE4 - TradingView
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 5.3% on Analyst Upgrade - MarketBeat
Nvidia To $323? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Truist Financial Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to "Buy" - MarketBeat
Tandem Diabetes Care analysts boost their forecasts after upbeat Q4 results - MSN
Tandem Diabetes (TNDM) Receives Upgrade Amid Revenue Growth Pros - GuruFocus
Tandem Diabetes (TNDM) EVP exercises 7,414 RSUs and sells 187 shares - Stock Titan
Lake Street upgrades Tandem Diabetes Care (TNDM) - MSN
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - Yahoo Finance
Piper Sandler upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes (TNDM) Stock Upgraded by Piper Sandler Amid Stra - GuruFocus
Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight - GuruFocus
Tandem Diabetes Care (TNDM) insider files resale notice; 2 shares sold at $45.62 - Stock Titan
Tandem Diabetes Care Stock Upgrade & Market Outlook 2026News and Statistics - IndexBox
Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance
Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga
TNDM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up on Analyst Upgrade - MarketBeat
Tandem stock rises as Piper Sandler upgrades (TNDM:NASDAQ) - Seeking Alpha
Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Piper Sandler - MarketBeat
Semtech To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Lemonade Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):